APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pregabalin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pregabalin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025191 pages

Choose your research edition.

Industry ResearchPregabalin Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pregabalin Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pregabalin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pregabalin Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Pregabalin Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Pregabalin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pregabalin include Zhejiang Huahai Pharmaceutical, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Changzhou Pharmaceutical Factory (CPF), ZCL Chemicals, Vasudha Pharma Chem, Srini Pharmaceuticals, Olon S.p.A. and Maps Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pregabalin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pregabalin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pregabalin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pregabalin market size, projected growth trends, production technologies, key applications, and end-use industries.

Pregabalin Segment by Company

Zhejiang Huahai Pharmaceutical

Teva Pharmaceutical Industries

Sun Pharmaceutical Industries

Changzhou Pharmaceutical Factory (CPF)

ZCL Chemicals

Vasudha Pharma Chem

Srini Pharmaceuticals

Olon S.p.A.

Maps Laboratories

Laurus Labs

Hikal

Glenmark Life Sciences

Dongbang FTL

Divi’s Laboratories

Divi’s Laboratories

CTX Life Sciences

Chemo Iberica

Bazayan

BAL Pharma

Aurobindo Pharma

ARITE Pharmaceutical

Angels Pharma

Almelo Pvt. Ltd.

AASraw Biochemical Technology

Pregabalin Segment by Type

Capsule

Oral Solution

Tablet

Pregabalin Segment by Application

Hospitals

Clinics

Others

Pregabalin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregabalin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pregabalin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregabalin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pregabalin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pregabalin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pregabalin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pregabalin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pregabalin Industry Trends Table 2. Pregabalin Industry Drivers Table 3. Pregabalin Industry Opportunities and Challenges Table 4. Pregabalin Industry Restraints Table 5. Global Pregabalin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pregabalin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pregabalin Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Pregabalin Sales Market Share by Manufacturers Table 9. Global Pregabalin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pregabalin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pregabalin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pregabalin Manufacturers, Product Type & Application Table 13. Global Pregabalin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pregabalin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsule Table 17. Major Manufacturers of Oral Solution Table 18. Major Manufacturers of Tablet Table 19. Global Pregabalin Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Pregabalin Sales by Type (2021-2026) & (W Units) Table 21. Global Pregabalin Sales by Type (2027-2032) & (W Units) Table 22. Global Pregabalin Sales Market Share by Type (2021-2026) Table 23. Global Pregabalin Sales Market Share by Type (2027-2032) Table 24. Global Pregabalin Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Pregabalin Revenue by Type (2021-2026) & (W Units) Table 26. Global Pregabalin Revenue by Type (2027-2032) & (W Units) Table 27. Global Pregabalin Revenue Market Share by Type (2021-2026) Table 28. Global Pregabalin Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Others Table 32. Global Pregabalin Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Pregabalin Sales by Application (2021-2026) & (W Units) Table 34. Global Pregabalin Sales by Application (2027-2032) & (W Units) Table 35. Global Pregabalin Sales Market Share by Application (2021-2026) Table 36. Global Pregabalin Sales Market Share by Application (2027-2032) Table 37. Global Pregabalin Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Pregabalin Revenue by Application (2021-2026) & (W Units) Table 39. Global Pregabalin Revenue by Application (2027-2032) & (W Units) Table 40. Global Pregabalin Revenue Market Share by Application (2021-2026) Table 41. Global Pregabalin Revenue Market Share by Application (2027-2032) Table 42. Global Pregabalin Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Pregabalin Sales by Region (2021-2026) & (W Units) Table 44. Global Pregabalin Sales Market Share by Region (2021-2026) Table 45. Global Pregabalin Sales Forecasted by Region (2027-2032) & (W Units) Table 46. Global Pregabalin Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pregabalin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 48. North America Pregabalin Sales by Country (2021-2026) & (W Units) Table 49. North America Pregabalin Sales by Country (2027-2032) & (W Units) Table 50. Europe Pregabalin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. Europe Pregabalin Sales by Country (2021-2026) & (W Units) Table 52. Europe Pregabalin Sales by Country (2027-2032) & (W Units) Table 53. Asia Pacific Pregabalin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Asia Pacific Pregabalin Sales by Country (2021-2026) & (W Units) Table 55. Asia Pacific Pregabalin Sales by Country (2027-2032) & (W Units) Table 56. South America, Middle East and Africa Pregabalin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. South America, Middle East and Africa Pregabalin Sales by Country (2021-2026) & (W Units) Table 58. South America, Middle East and Africa Pregabalin Sales by Country (2027-2032) & (W Units) Table 59. Global Pregabalin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pregabalin Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pregabalin Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pregabalin Revenue Market Share by Region (2021-2026) Table 63. Global Pregabalin Revenue Market Share by Region (2027-2032) Table 64. Zhejiang Huahai Pharmaceutical Company Information Table 65. Zhejiang Huahai Pharmaceutical Business Overview Table 66. Zhejiang Huahai Pharmaceutical Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio Table 68. Zhejiang Huahai Pharmaceutical Recent Development Table 69. Teva Pharmaceutical Industries Company Information Table 70. Teva Pharmaceutical Industries Business Overview Table 71. Teva Pharmaceutical Industries Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Teva Pharmaceutical Industries Pregabalin Product Portfolio Table 73. Teva Pharmaceutical Industries Recent Development Table 74. Sun Pharmaceutical Industries Company Information Table 75. Sun Pharmaceutical Industries Business Overview Table 76. Sun Pharmaceutical Industries Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sun Pharmaceutical Industries Pregabalin Product Portfolio Table 78. Sun Pharmaceutical Industries Recent Development Table 79. Changzhou Pharmaceutical Factory (CPF) Company Information Table 80. Changzhou Pharmaceutical Factory (CPF) Business Overview Table 81. Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio Table 83. Changzhou Pharmaceutical Factory (CPF) Recent Development Table 84. ZCL Chemicals Company Information Table 85. ZCL Chemicals Business Overview Table 86. ZCL Chemicals Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. ZCL Chemicals Pregabalin Product Portfolio Table 88. ZCL Chemicals Recent Development Table 89. Vasudha Pharma Chem Company Information Table 90. Vasudha Pharma Chem Business Overview Table 91. Vasudha Pharma Chem Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Vasudha Pharma Chem Pregabalin Product Portfolio Table 93. Vasudha Pharma Chem Recent Development Table 94. Srini Pharmaceuticals Company Information Table 95. Srini Pharmaceuticals Business Overview Table 96. Srini Pharmaceuticals Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Srini Pharmaceuticals Pregabalin Product Portfolio Table 98. Srini Pharmaceuticals Recent Development Table 99. Olon S.p.A. Company Information Table 100. Olon S.p.A. Business Overview Table 101. Olon S.p.A. Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Olon S.p.A. Pregabalin Product Portfolio Table 103. Olon S.p.A. Recent Development Table 104. Maps Laboratories Company Information Table 105. Maps Laboratories Business Overview Table 106. Maps Laboratories Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Maps Laboratories Pregabalin Product Portfolio Table 108. Maps Laboratories Recent Development Table 109. Laurus Labs Company Information Table 110. Laurus Labs Business Overview Table 111. Laurus Labs Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Laurus Labs Pregabalin Product Portfolio Table 113. Laurus Labs Recent Development Table 114. Hikal Company Information Table 115. Hikal Business Overview Table 116. Hikal Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Hikal Pregabalin Product Portfolio Table 118. Hikal Recent Development Table 119. Glenmark Life Sciences Company Information Table 120. Glenmark Life Sciences Business Overview Table 121. Glenmark Life Sciences Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Glenmark Life Sciences Pregabalin Product Portfolio Table 123. Glenmark Life Sciences Recent Development Table 124. Dongbang FTL Company Information Table 125. Dongbang FTL Business Overview Table 126. Dongbang FTL Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Dongbang FTL Pregabalin Product Portfolio Table 128. Dongbang FTL Recent Development Table 129. Divi’s Laboratories Company Information Table 130. Divi’s Laboratories Business Overview Table 131. Divi’s Laboratories Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Divi’s Laboratories Pregabalin Product Portfolio Table 133. Divi’s Laboratories Recent Development Table 134. Divi’s Laboratories Company Information Table 135. Divi’s Laboratories Business Overview Table 136. Divi’s Laboratories Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Divi’s Laboratories Pregabalin Product Portfolio Table 138. Divi’s Laboratories Recent Development Table 139. CTX Life Sciences Company Information Table 140. CTX Life Sciences Business Overview Table 141. CTX Life Sciences Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. CTX Life Sciences Pregabalin Product Portfolio Table 143. CTX Life Sciences Recent Development Table 144. Chemo Iberica Company Information Table 145. Chemo Iberica Business Overview Table 146. Chemo Iberica Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Chemo Iberica Pregabalin Product Portfolio Table 148. Chemo Iberica Recent Development Table 149. Bazayan Company Information Table 150. Bazayan Business Overview Table 151. Bazayan Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Bazayan Pregabalin Product Portfolio Table 153. Bazayan Recent Development Table 154. BAL Pharma Company Information Table 155. BAL Pharma Business Overview Table 156. BAL Pharma Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. BAL Pharma Pregabalin Product Portfolio Table 158. BAL Pharma Recent Development Table 159. Aurobindo Pharma Company Information Table 160. Aurobindo Pharma Business Overview Table 161. Aurobindo Pharma Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Aurobindo Pharma Pregabalin Product Portfolio Table 163. Aurobindo Pharma Recent Development Table 164. ARITE Pharmaceutical Company Information Table 165. ARITE Pharmaceutical Business Overview Table 166. ARITE Pharmaceutical Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. ARITE Pharmaceutical Pregabalin Product Portfolio Table 168. ARITE Pharmaceutical Recent Development Table 169. Angels Pharma Company Information Table 170. Angels Pharma Business Overview Table 171. Angels Pharma Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. Angels Pharma Pregabalin Product Portfolio Table 173. Angels Pharma Recent Development Table 174. Almelo Pvt. Ltd. Company Information Table 175. Almelo Pvt. Ltd. Business Overview Table 176. Almelo Pvt. Ltd. Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 177. Almelo Pvt. Ltd. Pregabalin Product Portfolio Table 178. Almelo Pvt. Ltd. Recent Development Table 179. AASraw Biochemical Technology Company Information Table 180. AASraw Biochemical Technology Business Overview Table 181. AASraw Biochemical Technology Pregabalin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 182. AASraw Biochemical Technology Pregabalin Product Portfolio Table 183. AASraw Biochemical Technology Recent Development Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Pregabalin Distributors List Table 187. Pregabalin Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Pregabalin Product Image Figure 2. Global Pregabalin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pregabalin Market Size (2021-2032) & (US$ Million) Figure 4. Global Pregabalin Sales (2021-2032) & (W Units) Figure 5. Global Pregabalin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pregabalin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsule Image Figure 9. Oral Solution Image Figure 10. Tablet Image Figure 11. Global Pregabalin Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Pregabalin Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pregabalin Sales Market Share by Type (2021-2032) Figure 14. Global Pregabalin Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Pregabalin Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pregabalin Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Pregabalin Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Pregabalin Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pregabalin Sales Market Share by Application (2021-2032) Figure 23. Global Pregabalin Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Pregabalin Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pregabalin Revenue Market Share by Application (2021-2032) Figure 26. North America Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 27. North America Pregabalin Sales Market Share by Country (2021-2032) Figure 28. U.S. Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Canada Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Mexico Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Pregabalin Sales Market Share by Country (2021-2032) Figure 33. Germany Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 34. France Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 35. U.K. Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Italy Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Netherlands Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Pregabalin Sales Market Share by Country (2021-2032) Figure 40. China Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Japan Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 42. South Korea Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Southeast Asia Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 44. India Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Australia Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Pregabalin Sales Market Share by Country (2021-2032) Figure 48. Brazil Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South Africa Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Saudi Arabia Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Turkey Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Argentina Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 53. UAE Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Egypt Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Chile Pregabalin Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Global Pregabalin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pregabalin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pregabalin Revenue (2021-2032) & (US$ Million) Figure 59. North America Pregabalin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pregabalin Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pregabalin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pregabalin Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pregabalin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pregabalin Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pregabalin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pregabalin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pregabalin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Oral Solution
  • Tablet
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Changzhou Pharmaceutical Factory (CPF)
  • ZCL Chemicals
  • Vasudha Pharma Chem
  • Srini Pharmaceuticals
  • Olon S.p.A.
  • Maps Laboratories
  • Laurus Labs
  • Hikal
  • Glenmark Life Sciences
  • Dongbang FTL
  • Divi’s Laboratories
  • Divi’s Laboratories
  • CTX Life Sciences
  • Chemo Iberica
  • Bazayan
  • BAL Pharma
  • Aurobindo Pharma
  • ARITE Pharmaceutical
  • Angels Pharma
  • Almelo Pvt. Ltd.
  • AASraw Biochemical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pregabalin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pregabalin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pregabalin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pregabalin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pregabalin Market Dynamics
  1. 2.1 Pregabalin Industry Trends
  2. 2.2 Pregabalin Industry Drivers
  3. 2.3 Pregabalin Industry Opportunities and Challenges
  4. 2.4 Pregabalin Industry Restraints
3 Pregabalin Market by Manufacturers
  1. 3.1 Global Pregabalin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pregabalin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pregabalin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pregabalin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pregabalin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pregabalin Manufacturers, Product Type & Application
  7. 3.7 Global Pregabalin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pregabalin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pregabalin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pregabalin Tier 1, Tier 2, and Tier 3
4 Pregabalin Market by Type
  1. 4.1 Pregabalin Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Oral Solution
  4. 4.1.3 Tablet
  5. 4.2 Global Pregabalin Sales by Type
  6. 4.2.1 Global Pregabalin Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pregabalin Sales by Type (2021-2032)
  8. 4.2.3 Global Pregabalin Sales Market Share by Type (2021-2032)
  9. 4.3 Global Pregabalin Revenue by Type
  10. 4.3.1 Global Pregabalin Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pregabalin Revenue by Type (2021-2032)
  12. 4.3.3 Global Pregabalin Revenue Market Share by Type (2021-2032)
5 Pregabalin Market by Application
  1. 5.1 Pregabalin Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Pregabalin Sales by Application
  6. 5.2.1 Global Pregabalin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pregabalin Sales by Application (2021-2032)
  8. 5.2.3 Global Pregabalin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pregabalin Revenue by Application
  10. 5.3.1 Global Pregabalin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pregabalin Revenue by Application (2021-2032)
  12. 5.3.3 Global Pregabalin Revenue Market Share by Application (2021-2032)
6 Global Pregabalin Sales by Region
  1. 6.1 Global Pregabalin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pregabalin Sales by Region (2021-2032)
  3. 6.2.1 Global Pregabalin Sales by Region (2021-2026)
  4. 6.2.2 Global Pregabalin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pregabalin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pregabalin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pregabalin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pregabalin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pregabalin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pregabalin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pregabalin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pregabalin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pregabalin Revenue by Region
  1. 7.1 Global Pregabalin Revenue by Region
  2. 7.1.1 Global Pregabalin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pregabalin Revenue by Region (2021-2026)
  4. 7.1.3 Global Pregabalin Revenue by Region (2027-2032)
  5. 7.1.4 Global Pregabalin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pregabalin Revenue (2021-2032)
  8. 7.2.2 North America Pregabalin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pregabalin Revenue (2021-2032)
  11. 7.3.2 Europe Pregabalin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pregabalin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pregabalin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pregabalin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pregabalin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Huahai Pharmaceutical
  2. 8.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio
  6. 8.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 8.2 Teva Pharmaceutical Industries
  8. 8.2.1 Teva Pharmaceutical Industries Company Information
  9. 8.2.2 Teva Pharmaceutical Industries Business Overview
  10. 8.2.3 Teva Pharmaceutical Industries Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceutical Industries Pregabalin Product Portfolio
  12. 8.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 8.3 Sun Pharmaceutical Industries
  14. 8.3.1 Sun Pharmaceutical Industries Company Information
  15. 8.3.2 Sun Pharmaceutical Industries Business Overview
  16. 8.3.3 Sun Pharmaceutical Industries Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Industries Pregabalin Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Industries Recent Developments
  19. 8.4 Changzhou Pharmaceutical Factory (CPF)
  20. 8.4.1 Changzhou Pharmaceutical Factory (CPF) Company Information
  21. 8.4.2 Changzhou Pharmaceutical Factory (CPF) Business Overview
  22. 8.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio
  24. 8.4.5 Changzhou Pharmaceutical Factory (CPF) Recent Developments
  25. 8.5 ZCL Chemicals
  26. 8.5.1 ZCL Chemicals Company Information
  27. 8.5.2 ZCL Chemicals Business Overview
  28. 8.5.3 ZCL Chemicals Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ZCL Chemicals Pregabalin Product Portfolio
  30. 8.5.5 ZCL Chemicals Recent Developments
  31. 8.6 Vasudha Pharma Chem
  32. 8.6.1 Vasudha Pharma Chem Company Information
  33. 8.6.2 Vasudha Pharma Chem Business Overview
  34. 8.6.3 Vasudha Pharma Chem Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vasudha Pharma Chem Pregabalin Product Portfolio
  36. 8.6.5 Vasudha Pharma Chem Recent Developments
  37. 8.7 Srini Pharmaceuticals
  38. 8.7.1 Srini Pharmaceuticals Company Information
  39. 8.7.2 Srini Pharmaceuticals Business Overview
  40. 8.7.3 Srini Pharmaceuticals Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Srini Pharmaceuticals Pregabalin Product Portfolio
  42. 8.7.5 Srini Pharmaceuticals Recent Developments
  43. 8.8 Olon S.p.A.
  44. 8.8.1 Olon S.p.A. Company Information
  45. 8.8.2 Olon S.p.A. Business Overview
  46. 8.8.3 Olon S.p.A. Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Olon S.p.A. Pregabalin Product Portfolio
  48. 8.8.5 Olon S.p.A. Recent Developments
  49. 8.9 Maps Laboratories
  50. 8.9.1 Maps Laboratories Company Information
  51. 8.9.2 Maps Laboratories Business Overview
  52. 8.9.3 Maps Laboratories Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Maps Laboratories Pregabalin Product Portfolio
  54. 8.9.5 Maps Laboratories Recent Developments
  55. 8.10 Laurus Labs
  56. 8.10.1 Laurus Labs Company Information
  57. 8.10.2 Laurus Labs Business Overview
  58. 8.10.3 Laurus Labs Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Laurus Labs Pregabalin Product Portfolio
  60. 8.10.5 Laurus Labs Recent Developments
  61. 8.11 Hikal
  62. 8.11.1 Hikal Company Information
  63. 8.11.2 Hikal Business Overview
  64. 8.11.3 Hikal Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hikal Pregabalin Product Portfolio
  66. 8.11.5 Hikal Recent Developments
  67. 8.12 Glenmark Life Sciences
  68. 8.12.1 Glenmark Life Sciences Company Information
  69. 8.12.2 Glenmark Life Sciences Business Overview
  70. 8.12.3 Glenmark Life Sciences Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Glenmark Life Sciences Pregabalin Product Portfolio
  72. 8.12.5 Glenmark Life Sciences Recent Developments
  73. 8.13 Dongbang FTL
  74. 8.13.1 Dongbang FTL Company Information
  75. 8.13.2 Dongbang FTL Business Overview
  76. 8.13.3 Dongbang FTL Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dongbang FTL Pregabalin Product Portfolio
  78. 8.13.5 Dongbang FTL Recent Developments
  79. 8.14 Divi’s Laboratories
  80. 8.14.1 Divi’s Laboratories Company Information
  81. 8.14.2 Divi’s Laboratories Business Overview
  82. 8.14.3 Divi’s Laboratories Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Divi’s Laboratories Pregabalin Product Portfolio
  84. 8.14.5 Divi’s Laboratories Recent Developments
  85. 8.15 Divi’s Laboratories
  86. 8.15.1 Divi’s Laboratories Company Information
  87. 8.15.2 Divi’s Laboratories Business Overview
  88. 8.15.3 Divi’s Laboratories Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Divi’s Laboratories Pregabalin Product Portfolio
  90. 8.15.5 Divi’s Laboratories Recent Developments
  91. 8.16 CTX Life Sciences
  92. 8.16.1 CTX Life Sciences Company Information
  93. 8.16.2 CTX Life Sciences Business Overview
  94. 8.16.3 CTX Life Sciences Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CTX Life Sciences Pregabalin Product Portfolio
  96. 8.16.5 CTX Life Sciences Recent Developments
  97. 8.17 Chemo Iberica
  98. 8.17.1 Chemo Iberica Company Information
  99. 8.17.2 Chemo Iberica Business Overview
  100. 8.17.3 Chemo Iberica Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Chemo Iberica Pregabalin Product Portfolio
  102. 8.17.5 Chemo Iberica Recent Developments
  103. 8.18 Bazayan
  104. 8.18.1 Bazayan Company Information
  105. 8.18.2 Bazayan Business Overview
  106. 8.18.3 Bazayan Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bazayan Pregabalin Product Portfolio
  108. 8.18.5 Bazayan Recent Developments
  109. 8.19 BAL Pharma
  110. 8.19.1 BAL Pharma Company Information
  111. 8.19.2 BAL Pharma Business Overview
  112. 8.19.3 BAL Pharma Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 BAL Pharma Pregabalin Product Portfolio
  114. 8.19.5 BAL Pharma Recent Developments
  115. 8.20 Aurobindo Pharma
  116. 8.20.1 Aurobindo Pharma Company Information
  117. 8.20.2 Aurobindo Pharma Business Overview
  118. 8.20.3 Aurobindo Pharma Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Aurobindo Pharma Pregabalin Product Portfolio
  120. 8.20.5 Aurobindo Pharma Recent Developments
  121. 8.21 ARITE Pharmaceutical
  122. 8.21.1 ARITE Pharmaceutical Company Information
  123. 8.21.2 ARITE Pharmaceutical Business Overview
  124. 8.21.3 ARITE Pharmaceutical Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 ARITE Pharmaceutical Pregabalin Product Portfolio
  126. 8.21.5 ARITE Pharmaceutical Recent Developments
  127. 8.22 Angels Pharma
  128. 8.22.1 Angels Pharma Company Information
  129. 8.22.2 Angels Pharma Business Overview
  130. 8.22.3 Angels Pharma Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Angels Pharma Pregabalin Product Portfolio
  132. 8.22.5 Angels Pharma Recent Developments
  133. 8.23 Almelo Pvt. Ltd.
  134. 8.23.1 Almelo Pvt. Ltd. Company Information
  135. 8.23.2 Almelo Pvt. Ltd. Business Overview
  136. 8.23.3 Almelo Pvt. Ltd. Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Almelo Pvt. Ltd. Pregabalin Product Portfolio
  138. 8.23.5 Almelo Pvt. Ltd. Recent Developments
  139. 8.24 AASraw Biochemical Technology
  140. 8.24.1 AASraw Biochemical Technology Company Information
  141. 8.24.2 AASraw Biochemical Technology Business Overview
  142. 8.24.3 AASraw Biochemical Technology Pregabalin Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 AASraw Biochemical Technology Pregabalin Product Portfolio
  144. 8.24.5 AASraw Biochemical Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pregabalin Value Chain Analysis
  2. 9.1.1 Pregabalin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pregabalin Production Mode & Process
  6. 9.2 Pregabalin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pregabalin Distributors
  9. 9.2.3 Pregabalin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst